About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Multiple Sclerosis Clinical Trials in New York | 58 Studies

Clinical Trials Multiple SclerosisNew York

Multiple Sclerosis Clinical Trials in New York

Find 58 clinical trials for multiple sclerosis near New York, New York. Connect with research centers in your area.

All Multiple Sclerosis trials nationwide All trials in New York

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 1-20 of 58 trials

TerminatedStudy to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis AttacksThis clinical trial compares the relative efficacy of treating acute exacerbations of relapsing forms of Multiple Sclerosis with equivalent doses of oral and intravenous (IV)…NCT00418145·New Brunswick, New Jersey and 9 others TerminatedVideofluoroscopic Swallowing Study (VFSS)The study procedure of simultaneous VFSS and DDS measurement will be completed in one day and the subject will be followed within 2 business days after the study procedure to…NCT03387267·Downey, California and 12 others TerminatedEffect of MD1003 in Progressive Multiple Sclerosis (SPI2)The purpose of this study is to demonstrate the superiority of MD1003 over placebo in the disability of patients suffering from progressive multiple sclerosis and especially those…NCT02936037·Phoenix, Arizona and 91 others

Multiple Sclerosis Trials in Other Cities

Los Angeles Chicago Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

UnknownAnalysis of MS Patients Who Have Had Greater Than 60 Infusions of NatalizumabThe purpose of this study is to explore the safety and efficacy data in clinic patients who have been treated with Natalizumab for more than 60 continuous infusions.NCT04964700·Latham, New York

CompletedEnvironmental and Genetic Risk Factors for Pediatric Multiple SclerosisThe purpose of this study is to better understand multiple sclerosis (MS) in children and adolescents, to learn if it differs from adult MS and to investigate if genes or…NCT01396343·Birmingham, Alabama and 16 others

UnknownTask Specific Training for Advanced Multiple SclerosisThe purpose of this study is to find effective physical therapy treatments for individuals who have severe multiple sclerosis.NCT06506929·New York, New York

CompletedStudy of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple SclerosisThe purpose of this study is to determine whether Tcelna (imilecleucel-T, autologous T-Cell Immunotherapy) is effective in the treatment of secondary progressive multiple…NCT01684761·Phoenix, Arizona and 35 others

CompletedEfficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple SclerosisThis study assessed the safety, tolerability and efficacy of two doses of oral fingolimod compared to placebo on efficacy parameters in patients with relapsing-remitting multiple…NCT00355134·Birmingham, Alabama and 111 others

CompletedPilot Study of Transcranial Direct Current Stimulation (tDCS)This study will test the tolerability and preliminary efficacy of transcranial direct current stimulation (tDCS) combined with a cognitive training program, remotely-delivered…NCT02746705·New York, New York

CompletedSafety of Xeomin for Lower Limb Spasticity in Multiple Sclerosis PatientsThe purpose of this study is to determine if Xeomin® will prove effective for significantly improving lower extremity spasticity and will be well tolerated by the majority of MS…NCT01968902·Latham, New York

CompletedSafety and Efficacy of Natalizumab in Combination With Avonex in the Treatment of Multiple SclerosisThe purpose of this study is to determine if natalizumab in combination with AVONEX is safe and effective in delaying progression of individuals diagnosed with relapsing remitting…NCT00030966·Birmingham, Alabama and 87 others

UnknownOptic Neuritis Treatment Trial (ONTT)To assess the beneficial and adverse effects of corticosteroid treatment for optic neuritis. To determine the natural history of vision in patients who suffer optic neuritis.NCT00000146·Little Rock, Arkansas and 14 others

CompletedTraditional Versus Early Aggressive Therapy for Multiple Sclerosis TrialFDA-approved multiple sclerosis (MS) disease-modifying therapies (DMTs) target the relapsing phase of MS but have minimal impact once the progressive phase has begun.NCT03500328·Birmingham, Alabama and 46 others

CompletedpH-weighted MRI in Multiple Sclerosis: A Surrogate Marker of Tissue Metabolic StressTwenty subjects (10 patients and 10 age-matched control volunteers) will be recruited for this study.NCT03028675·New York, New York

CompletedEvaluation of the Onset of Action in Highly Active MS (MAGNIFY)The main purpose of the study was to determine the onset of Mavenclad® action by frequent magnetic resonance imaging (MRI) assessment of the combined unique active (CUA) lesions…NCT03364036·Sydney, New South Wales and 53 others

CompletedRELAXaHEAD for Headache Patients (Phase I)The goal of this research is to assess the utility of smartphone-based progressive muscle relaxation (PMR) for the treatment of headaches.NCT03183791·New York, New York

TerminatedDysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 1The purpose of this study is to provide confirmatory evidence of the safety and efficacy of two Dysport® (AbobotulinumtoxinA) doses (600 units \[U\] and 800 U), compared to…NCT02660138·Birmingham, Alabama and 80 others

TerminatedSingle Center, Open Label, Study of Preparation H on Erythema in Relapsing MS Patients Treated With PLEGRIDYThe primary purpose of this single center, randomized, open label study in relapsing Multiple Sclerosis (MS) patients on PLEGRIDY (peginterferon beta-1a) is to assess the effect…NCT02665221·New York, New York

CompletedA Study of the Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple SclerosisThis is a phase II, multicenter, randomized, parallel-group, partially blinded, placebo and Avonex (interferon beta-1a) controlled dose finding study to evaluate the efficacy as…NCT00676715·Phoenix, Arizona and 83 others

No longer availableExpanded Access to Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Progressive Multiple SclerosisTo give expanded access to intrathecal autologous MSC-NP treatment to patients with progressive MS who do not meet the inclusion/exclusion criteria of our Phase II stem cell trial.NCT03822858·New York, New York

Page 1 of 3Next

Other Conditions in New York

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia